BioAccel Announces Solutions Challenge 2016 Competition Categories
BioAccel (@BioAccel) , an organization dedicated to supporting earlystage medical device and technology entrepreneurs, is recruiting entrepreneur teams to compete in its premiere event, The Solutions Challenge (#SolutionsChallenge), scheduled for Thursday, December 1, 2016.
The BioAccel Solutions Challenge is an exciting annual, med-tech innovator competition that challenges entrepreneurs to solve critical healthcare needs through the advancement of medical device and information technology solutions. Entrepreneurs are encouraged to form multidisciplinary innovation teams that will be vetted through a rigorous application process. Selected finalists will pitch their medical innovation and business plan during a Scorpion Pit (Arizona’s equivalent to “Shark Tank”) judging event.
BioAccel identifies local “Scorpions”, individuals willing to invest in early-stage, innovative companies solving healthcare issues. Participants must convince the Scorpions to invest in their company and BioAccel will match up to $50,000 of their investment as part of our Technology Advancement Program. Teams can win up to $100,000 in seed funding and obtain valuable feedback and mentoring important to launching a successful company.
The online application deadline is Monday, September 26, 2016.
BioAccel’s Scorpion Pit Competition will be held during the afternoon from 1 p.m. to 4:30 p.m., followed by a hosted award cocktail reception/celebration from 4:30 p.m. to approximately 6:30 p.m., when biomedical company winners and levels of funding will be announced. The evening will conclude with a closing reception and music entertainment from 6:30 p.m. to 8 p.m.
Solutions Challenge 2016 Categories
For the 2016 Solutions Challenge, special consideration will be given to ventures that in addition to addressing one of the Challenge Categories, also positively affect, impact or focus on behavioral/mental health patients and aging populations. See Challenge Categories and read more.
